Cases of the highly infectious bacteria Clostridioides difficile, or C. diff, which has killed thousands have soared to a 12 year high.

University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides difficile (C. diff) among adults given low-dose oral vancomycin ...

C. difficile infection recurrence rates were numerically lower with vancomycin than with placebo, though the difference was not significant. However, the results could be clinically meaningful, an ...

(HealthDay News) — Fecal microbiota transplantation (FMT) could be considered as first-line therapy for primary Clostridioides difficile infection (CDI), according to a study published online ...

Fecal microbiota transplantation (FMT) could be considered as first-line therapy for primary Clostridioides difficile infection.

Some new members of the C.D.C.’s Advisory Committee on Immunization Practices, handpicked by health secretary Robert F. Kennedy Jr., have expressed deep skepticism of vaccines. One of them ...

(RTTNews) - Acurx Pharmaceuticals, Inc. (ACXP) Monday announced that its lead antibiotic candidate, ibezapolstat, is advancing to international Phase 3 clinical trials for treating C. difficile ...

Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease duration, previous use of corticosteroids, and prior hospitalisation.

Paul Feuerstadt, MD, FACG, AGAF, discusses how the management of recurrent Clostridioides difficile infections is evolving toward more targeted approaches, including microbiome-based therapies ...

Acurx's lead product candidate, ibezapolstat, for the treatment of C. difficile Infection is Phase 3 ready with plans in progress to begin international clinical trials next year.

The Food and Drug Administration must act so patients with refractory C. difficile infection can access lifesaving fecal transplants.

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to-treat Clostridioides difficile bacteria, using the technology behind ...